Donepezil News

Court of Appeal orders NICE to be more open

NICE warns drug appraisals could take longer after drug manufacturers win Alzheimer's legal challenge.

When Added to Donepezil Therapy, Memantine Enhances Communication Abilities in Patients With Moderate to Severe Alzheimer's Disease: Presented at AGS

Memantine significantly improves naming and functional communication skills in patients with Alzheimer's disease, thus facilitating social interaction between patient and caregiver, researchers reported here at the 2008 American...

EPIX Pharmaceuticals Initiates Phase 2b Program in Alzheimer’s Disease

EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today...

Memantine Improves Communication Abilities in Patients With Moderate-to-Severe Alzheimer's Disease: Presented at AAT

Memantine significantly improved naming ability and functional communication in donepezil-treated patients with moderate-to-severe Alzheimer's disease (AD) compared with placebo.

Executive Cognitive Function In CADASIL Patients May Be Improved By Taking Donepezil

According to an article published in the April edition of The Lancet Neurology, donepezil may improve the executive function of patients who suffer from the CADASIL form of vascular dementia. However, researcher Martin Dichgans...

Displaying results 1 to 5 out of 30

1

2

3

4

5

6

Next >

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.